Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H

As of June 30, 2024, Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H carries a market capitalization of 239.95M, placing it among publicly traded companies globally. Its enterprise value stands at 40.01M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2024, Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H has 1.68B shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H maintains a current ratio of 2.81, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2024.

Over the twelve months ended June 30, 2024, Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H recorded 14.01M in income tax expense.

As of the close on October 22, 2026, Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H's stock has declined approximately 36.91% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.13.

As of June 30, 2024, Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H holds 421.14M in cash and equivalents against 101.54M in total debt, resulting in a net debt position of -239.13M. Total book value stands at 1.02B, with working capital of 644.56M providing operational flexibility.